RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Combination of daidzein, hemin and bms182874 halts the progression of diabetes-induced experimental nephropathy.

Combination of daidzein, hemin and bms182874 halts the progression of diabetes-induced experimental nephropathy.

Add to Collection
2013 Jun Others Fist_Author_Year_PM

Full Author : ['Katyal, Taruna', 'Garg, Arun', 'Budhiraja, R D']
Journal Title : Endocrine, metabolic & immune disorders drug targets
Chapter : Section3
Journal Year : 2013
Cited by : Not Available

The present study has been designed to investigate the combined effect of daidzein (caveolin inhibitor), hemin (hemoxygenase activator) and BMS182874 (endothelin receptor antagonist) in diabetic nephropathy in wistar rats. Diabetic nephropathy was induced.....

Keywords : ["diabetesinduced experimental nephropathy", "daidzein hemin", "progression", "halt", "combination"]